Komori
Ube (4208) · RiskWorsenedLatest Results presentation (2026-08-07): "Mitigated"

Interest Rate Fluctuations and Changes in Financing Conditions

First written in FY2016. 3 of 7 entries say "Worsened", first in FY2025. Latest entry: 2026-08-07.

7entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20212016: 120162017: 020172018: 120182019: 020192020: 020202021: 120212022: 020222023: 020232024: 020242025: 120252026: 32026
Same theme, other companies
Risk of higher financing costs due to financial market instability and rising interest ratesA theme 83 companies write about · 84 as a headwind · 0 as a tailwind

Ube moved to the "Worse" side of this theme in 2025, 2 years after the typical company in this theme (2023).

The whole theme swung hardest in 2025: 11 of 33 companies on the "Worse" side.

13 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 83 companies compared. The sentences above are computed from all 83.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-07MitigatedResults presentation

    「持分法適用関連会社であるUBE三菱セメント㈱から受領した配当金により有利子負債を削減。」

    UBE三菱セメントからの配当金を受け、有利子負債が前年度末の3,582億円から3,403億円へ減少しました。
  2. FY2026WorsenedAnnual report

    「Interest-bearing debt increased by ¥27.636 billion, or 8.4%, to ¥358.172 billion.」

    Interest-bearing debt increased against the backdrop of large-scale investments and the acquisition of the LANXESS business, while cash and cash equivalents declined by ¥6.2859 billion to ¥5.2583 billion. The figures indicate a greater investment burden in financial management.
  3. 2026-05-13WorsenedResults presentation

    「有利子負債 3,305 3,582 4,150」

    有利子負債は前年度の3,305億円から2026年3月期に3,582億円へ増加し、2027年3月期は4,150億円が計画されています。
  4. FY2025WorsenedAnnual report

    「The new medium-term management plan calls for high levels of capital investment and investment and financing, so a temporary increase in financial stress is anticipated.」

    The possibility of temporary financial stress associated with growth investments was explicitly noted. Interest-bearing debt stood at ¥330.536 billion, up 54.9% from the previous fiscal year.
  5. FY2021RestatedAnnual report

    「The Group is working to mitigate the impact of changes in the funding environment by maintaining sufficient liquidity through cash and deposits, committed lines and other sources, while spreading repayment and redemption maturities and diversifying funding methods.」

    The Group continues to address funding risks by securing liquidity, spreading repayment maturities and diversifying funding methods.
  6. FY2018RestatedAnnual report

    「The Group mitigates foreign exchange and interest rate risk to a certain extent through hedging transactions such as forward exchange contracts and interest rate swaps.」

    Interest rate risk and measures such as interest rate swaps were reiterated.
  7. FY2016First statedAnnual report

    「The Group mitigates interest rate risk to a certain extent through hedging transactions such as interest rate swaps, but interest rate movements exceeding short-, medium- and long-term forecasts may adversely affect the Group's operating results and financial position.」

    Interest rate risk on borrowings and financial market trends were noted.
Moved together

"Approval, commercialization and R&D risks in the active pharmaceutical ingredient and intermediate business" moved the same way as this thread, in the same document, in 2 of its 7 moves.

222222★123456
  1. ★This thread
  2. 1Approval, commercialization and R&D risks in the active pharmaceutical ingredient and intermediate business2×
  3. 2Multiple business segments spanning chemicals, pharmaceuticals, construction materials, machinery and energy2×
  4. 3Performance-linked dividends and returns to shareholders2×
  5. 4Substantial Recovery in Operating Profit2×
  6. 5Improvement in the Equity Ratio2×
  7. 6Expansion of silicon nitride ceramics production facilities2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Ube's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Results presentation of 2026-08-07: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.